A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

NCT00002177 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Hydroxyurea
DRUG: Nelfinavir mesylate
DRUG: Stavudine
DRUG: Didanosine

Sponsor

Bristol-Myers Squibb